Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer in vitro and in vivo

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Zhu, Wei ^a   Wei, Lai ^a   Zhang, Hongwei ^a   Chen, Junxue ^a   Qin, Xinyu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; IL 24; Oncolytic adenovirus

Indexed keywords

INTERLEUKIN 24; ONCOLYTIC ADENOVIRUS;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TUMOR GROWTH; VIRUS REPLICATION; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENETIC VECTORS; HUMANS; INTERLEUKINS; MICE; MICE, NUDE; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; RECOMBINANT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861420850     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-51     Document Type: Article

References (24)

1. Global Cancer Facts & Figures. Garcia M JA, Ward EM, Center MM, Hao Y, Siegel RL, Thun MJ, Book Global Cancer Facts & Figures (Editor ed. eds.), 12 edition. City: American Cancer Society 2007
2. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Saeki T, Mhashilkar A, Swanson X, Zou-Yang XH, Sieger K, Kawabe S, Branch CD, Zumstein L, Meyn RE, Roth JA, et al. Oncogene 2002 21 4558 4566 10.1038/sj.onc.1205553 12085234 (Pubitemid 34785732)
3. Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Ramesh R, Ito I, Gopalan B, Saito Y, Mhashilkar AM, Chada S, Mol Ther 2004 9 510 518 10.1016/j.ymthe.2004.01.019 15093181 (Pubitemid 38578801)
4. mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Gupta P, Su ZZ, Lebedeva IV, Sarkar D, Sauane M, Emdad L, Bachelor MA, Grant S, Curiel DT, Dent P, Fisher PB, Pharmacol Ther 2006 111 596 628 10.1016/j.pharmthera.2005.11.005 16464504 (Pubitemid 44118431)
5. Targeted IL-24 gene therapy inhibits cancer recurrence after liver tumor resection by inducing tumor cell apoptosis in nude mice. Yang YJ, Chen DZ, Li LX, Sheng QS, Jin ZK, Zhao DF, Hepatobiliary Pancreat Dis Int 2009 8 174 178 19357032
6. The in vitro and in vivo antitumor activity of adenovirus-mediated interleukin-24 expression for laryngocarcinoma. Liu J, Sheng W, Xie Y, Shan Y, Miao J, Xiang J, Yang J, Cancer Biother Radiopharm 2010 25 29 38 10.1089/cbr.2009.0706 20187794
7. Oncolytic adenoviruses targeted to cancer stem cells. Short JJ, Curiel DT, Mol Cancer Ther 2009 8 2096 2102 10.1158/1535-7163.MCT-09-0367 19671759
8. Oncolytic viruses for cancer therapy: overcoming the obstacles. Wong HH, Lemoine NR, Wang Y, Viruses 2010 2 78 106 10.3390/v2010078 20543907
9. Targeting gene-virotherapy of cancer. Liu XY, Gu JF, Cell Res 2006 16 25 30 10.1038/sj.cr.7310005 16467873 (Pubitemid 43129306)
10. Oncolytic viruses driven by tumor-specific promoters. Hardcastle J, Kurozumi K, Chiocca EA, Kaur B, Curr Cancer Drug Targets 2007 7 181 189 10.2174/156800907780058880 17346110 (Pubitemid 46348633)
11. Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer. Lu Y, Adv Drug Deliv Rev 2009 61 572 588 10.1016/j.addr.2009.03.014 19393705
12. Use of replicating oncolytic adenoviruses in combination therapy for cancer. Chu RL, Post DE, Khuri FR, Van Meir EG, Clin Cancer Res 2004 10 5299 5312 10.1158/1078-0432.CCR-0349-03 15328165 (Pubitemid 39100464)
13. Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus. Wang W, Jin B, Li W, Xu CX, Cui FA, Liu B, Yan YF, Liu XX, Wang XL, Mol Biol Rep 2010 37 3239 3247 10.1007/s11033-009-9908-5 19876766
14. In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific oncolytic virotherapy. Kojima T, Watanabe Y, Hashimoto Y, Kuroda S, Yamasaki Y, Yano S, Ouchi M, Tazawa H, Uno F, Kagawa S, et al. Ann Surg 2010 251 1079 1086 10.1097/SLA.0b013e3181deb69d 20485131
15. Hypoxia-mediated tumour targeting. Binley K, Askham Z, Martin L, Spearman H, Day D, Kingsman S, Naylor S, Gene Ther 2003 10 540 549 10.1038/sj.gt.3301944 12646859 (Pubitemid 36432605)
16. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C, Shi W, Su C, Wu H, Liu X, et al. Clin Cancer Res 2006 12 6523 6531 10.1158/1078-0432.CCR-06-1491 17085667 (Pubitemid 44799727)
17. Micrometastases or isolated tumor cells and the outcome of breast cancer. de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM, Nortier JW, Rutgers EJ, Seynaeve C, Menke-Pluymers MB, et al. N Engl J Med 2009 361 653 663 10.1056/NEJMoa0904832 19675329
18. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10. Zheng M, Bocangel D, Doneske B, Mhashilkar A, Ramesh R, Hunt KK, Ekmekcioglu S, Sutton RB, Poindexter N, Grimm EA, Chada S, Cancer Immunol Immunother 2007 56 205 215 16710719 (Pubitemid 44833094)
19. Tumour suppressor function of MDA-7/IL-24 in human breast cancer. Patani N, Douglas-Jones A, Mansel R, Jiang W, Mokbel K, Cancer Cell Int 2010 10 29 20735832
20. MDA-7/IL-24 as a cancer therapeutic: from bench to bedside. Dent P, Yacoub A, Hamed HA, Park MA, Dash R, Bhutia SK, Sarkar D, Gupta P, Emdad L, Lebedeva IV, et al. Anticancer Drugs 2010 21 725 731 10.1097/CAD. 0b013e32833cfbe1 20613485
21. Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer. Ramesh R, Ioannides CG, Roth JA, Chada S, Methods Mol Biol 2010 651 241 270 10.1007/978-1-60761-786-0-14 20686970
22. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Sarkar D, Su ZZ, Vozhilla N, Park ES, Gupta P, Fisher PB, Proc Natl Acad Sci U S A 2005 102 14034 14039 10.1073/pnas.0506837102 16172403 (Pubitemid 41377698)
23. Double-regulated oncolytic adenovirus-mediated interleukin-24 overexpression exhibits potent antitumor activity on gastric adenocarcinoma. Wei N, Fan JK, Gu JF, Liu XY, Hum Gene Ther 2010 21 855 864 10.1089/hum.2009.207 20163249
24. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, Bata A, Campbell K, Coffee R, Gorodinsky A, et al. PLoS One 2010 5 9364 10.1371/journal.pone.0009364 20186331